本页面由Tiger Trade Technology Pte. Ltd.提供服务

Editas Medicine, Inc.

2.65
-0.0050-0.19%
成交量:27.68万
成交额:73.37万
市值:4.05亿
市盈率:-3.62
高:2.72
开:2.72
低:2.62
收:2.65
52周最高:4.54
52周最低:1.66
股本:1.53亿
流通股本:1.15亿
量比:1.89
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-0.7307
每股收益(LYR):-1.8036
净资产收益率:-118.82%
总资产收益率:-23.29%
市净率:3.84
市盈率(LYR):-1.47

数据加载中...

2026/09/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/02

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/07

重要事件披露

Form 8-K - Current report